Clinical characteristics and outcomes in elderly patients undergoing transsphenoidal surgery for nonfunctioning pituitary adenoma
- PMID: 33002877
- DOI: 10.3171/2020.7.FOCUS20524
Clinical characteristics and outcomes in elderly patients undergoing transsphenoidal surgery for nonfunctioning pituitary adenoma
Abstract
Objective: Life expectancy has increased over the past century, causing a shift in the demographic distribution toward older age groups. Elderly patients comprise up to 14% of all patients with pituitary tumors, with most lesions being nonfunctioning pituitary adenomas (NFPAs). Here, the authors evaluated demographics, outcomes, and postoperative complications between nonelderly adult and elderly NFPA patients.
Methods: A retrospective review of 908 patients undergoing transsphenoidal surgery (TSS) for NFPA at a single institution from 2007 to 2019 was conducted. Clinical and surgical outcomes and postoperative complications were compared between nonelderly adult (age ≥ 18 and ≤ 65 years) and elderly patients (age > 65 years).
Results: There were 614 and 294 patients in the nonelderly and elderly groups, respectively. Both groups were similar in sex (57.3% vs 60.5% males; p = 0.4), tumor size (2.56 vs 2.46 cm; p = 0.2), and cavernous sinus invasion (35.8% vs 33.7%; p = 0.6). Regarding postoperative outcomes, length of stay (1 vs 2 days; p = 0.5), extent of resection (59.8% vs 64.8% gross-total resection; p = 0.2), CSF leak requiring surgical revision (4.3% vs 1.4%; p = 0.06), 30-day readmission (8.1% vs 7.3%; p = 0.7), infection (3.1% vs 2.0%; p = 0.5), and new hypopituitarism (13.9% vs 12.0%; p = 0.3) were similar between both groups. Elderly patients were less likely to receive adjuvant radiation (8.7% vs 16.3%; p = 0.009), undergo future reoperation (3.8% vs 9.5%; p = 0.003), and experience postoperative diabetes insipidus (DI) (3.7% vs 9.4%; p = 0.002), and more likely to have postoperative hyponatremia (26.7% vs 16.4%; p < 0.001) and new cranial nerve deficit (1.9% vs 0.0%; p = 0.01). Subanalysis of elderly patients showed that patients with higher Charlson Comorbidity Index scores had comparable outcomes other than higher DI rates (8.1% vs 0.0%; p = 0.006). Elderly patients' postoperative sodium peaked and troughed on postoperative day 3 (POD3) (mean 138.7 mEq/L) and POD9 (mean 130.8 mEq/L), respectively, compared with nonelderly patients (peak POD2: mean 139.9 mEq/L; trough POD8: mean 131.3 mEq/L).
Conclusions: The authors' analysis revealed that TSS for NFPA in elderly patients is safe with low complication rates. In this cohort, more elderly patients experienced postoperative hyponatremia, while more nonelderly patients experienced postoperative DI. These findings, combined with the observation of higher DI in patients with more comorbidities and elderly patients experiencing later peaks and troughs in serum sodium, suggest age-related differences in sodium regulation after NFPA resection. The authors hope that their results will help guide discussions with elderly patients regarding risks and outcomes of TSS.
Keywords: CCI = Charlson Comorbidity Index; CN = cranial nerve; CS = cavernous sinus; DI = diabetes insipidus; EBL = estimated blood loss; EOR = extent of resection; ETSS = endoscopic TSS; GTR = gross-total resection; LOS = length of stay; MTSS = microscopic TSS; NFPA = nonfunctioning PA; PA = pituitary adenoma; POD = postoperative day; SIADH = syndrome of inappropriate antidiuretic hormone secretion; STR = subtotal resection; TSS = transsphenoidal surgery; elderly; geriatric; nonfunctioning pituitary adenoma; transsphenoidal surgery.
Similar articles
-
Comparison of outcomes between a less experienced surgeon using a fully endoscopic technique and a very experienced surgeon using a microscopic transsphenoidal technique for pituitary adenoma.J Neurosurg. 2016 Mar;124(3):596-604. doi: 10.3171/2015.4.JNS15102. Epub 2015 Oct 16. J Neurosurg. 2016. PMID: 26473774
-
Hypopituitarism after Gamma Knife surgery for postoperative nonfunctioning pituitary adenoma.J Neurosurg. 2018 Dec 1;129(Suppl1):47-54. doi: 10.3171/2018.7.GKS181589. J Neurosurg. 2018. PMID: 30544293
-
Primary versus revision transsphenoidal resection for nonfunctioning pituitary macroadenomas: matched cohort study.J Neurosurg. 2017 Mar;126(3):889-896. doi: 10.3171/2016.3.JNS152735. Epub 2016 May 20. J Neurosurg. 2017. PMID: 27203142
-
Endoscopic endonasal transsphenoidal surgery in elderly patients with pituitary adenomas.J Neurosurg. 2015 Jul;123(1):31-8. doi: 10.3171/2014.10.JNS14372. Epub 2015 Apr 3. J Neurosurg. 2015. PMID: 25839926 Review.
-
Gross total resection of pituitary adenomas after endoscopic vs. microscopic transsphenoidal surgery: a meta-analysis.Acta Neurochir (Wien). 2018 May;160(5):1005-1021. doi: 10.1007/s00701-017-3438-z. Epub 2018 Jan 6. Acta Neurochir (Wien). 2018. PMID: 29307020 Free PMC article. Review.
Cited by
-
Visual outcomes and optimal timing for repeat surgery in cases of postoperative hematoma following transsphenoidal surgery for pituitary neuroendocrine tumors: A retrospective cohort study.Acta Neurochir (Wien). 2024 Mar 9;166(1):127. doi: 10.1007/s00701-024-06027-9. Acta Neurochir (Wien). 2024. PMID: 38460009
-
Comparative analysis of clinical characteristics of symptomatic pituitary adenomas in elderly patients: a consecutive series of 114 patients.Front Endocrinol (Lausanne). 2024 Dec 6;15:1385813. doi: 10.3389/fendo.2024.1385813. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39713056 Free PMC article.
-
Different tumor growth pattern of clinically nonfunctioning pituitary neuroendocrine tumor according to sex and age: a longitudinal study.J Endocrinol Invest. 2024 Aug;47(8):1911-1921. doi: 10.1007/s40618-024-02303-8. Epub 2024 Feb 4. J Endocrinol Invest. 2024. PMID: 38310625 Free PMC article.
-
Pituitary incidentaloma: a Pituitary Society international consensus guideline statement.Nat Rev Endocrinol. 2025 Jun 24. doi: 10.1038/s41574-025-01134-8. Online ahead of print. Nat Rev Endocrinol. 2025. PMID: 40555795 Review.
-
Endoscopic vs. microscopic transsphenoidal surgery outcomes in 514 nonfunctioning pituitary adenoma cases.Neurosurg Rev. 2022 Jun;45(3):2375-2383. doi: 10.1007/s10143-022-01732-4. Epub 2022 Mar 1. Neurosurg Rev. 2022. PMID: 35230574
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous